These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11997073)

  • 1. Hemiparkinsonism associated with a mesencephalic tumor.
    Yoshimura M; Yamamoto T; Iso-o N; Imafuku I; Momose T; Shirouzu I; Kwak S; Kanazawa I
    J Neurol Sci; 2002 May; 197(1-2):89-92. PubMed ID: 11997073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.
    Leenders KL; Salmon EP; Tyrrell P; Perani D; Brooks DJ; Sager H; Jones T; Marsden CD; Frackowiak RS
    Arch Neurol; 1990 Dec; 47(12):1290-8. PubMed ID: 2123623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst.
    Singer C; Schatz NJ; Bowen B; Eidelberg D; Kazumata K; Sternau L; Shulman LM; Weiner WJ
    Mov Disord; 1998 Jan; 13(1):135-9. PubMed ID: 9452338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical utility of (18)F-DOPA-PET in movement disorders. A systematic review].
    Puñal-Riobóo J; Serena-Puig A; Varela-Lema L; Alvarez-Páez AM; Ruano-Ravina A
    Rev Esp Med Nucl; 2009; 28(3):106-13. PubMed ID: 19558950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure Hemiparkinsonism Secondary to Contralateral Lacunar Stroke in the Substantia Nigra.
    Robles LA
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):e20-1. PubMed ID: 26639402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.
    Ma Y; Feigin A; Dhawan V; Fukuda M; Shi Q; Greene P; Breeze R; Fahn S; Freed C; Eidelberg D
    Ann Neurol; 2002 Nov; 52(5):628-34. PubMed ID: 12402261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.
    Ernst M; Zametkin AJ; Matochik JA; Pascualvaca D; Jons PH; Cohen RM
    Am J Psychiatry; 1999 Aug; 156(8):1209-15. PubMed ID: 10450262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
    Piccini P; de Yebenez J; Lees AJ; Ceravolo R; Turjanski N; Pramstaller P; Brooks DJ
    Arch Neurol; 2001 Nov; 58(11):1846-51. PubMed ID: 11708994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic utility of positron emission tomography for parkinsonism after chronic manganese exposure].
    Abe Y; Kachi T; Kato T; Ito K; Yanagisawa N; Sobue G
    Rinsho Shinkeigaku; 1999 Jul; 39(7):693-9. PubMed ID: 10548904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
    Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
    Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging and 11C-N-methylspiperone/positron emission tomography studies in a patient with the interval form of carbon monoxide poisoning.
    Yoshii F; Kozuma R; Takahashi W; Haida M; Takagi S; Shinohara Y
    J Neurol Sci; 1998 Sep; 160(1):87-91. PubMed ID: 9804123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
    Vidailhet M; Dupel C; Lehéricy S; Remy P; Dormont D; Serdaru M; Jedynak P; Veber H; Samson Y; Marsault C; Agid Y
    Arch Neurol; 1999 Aug; 56(8):982-9. PubMed ID: 10448804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
    Blesa J; Juri C; Collantes M; Peñuelas I; Prieto E; Iglesias E; Martí-Climent J; Arbizu J; Zubieta JL; Rodríguez-Oroz MC; García-García D; Richter JA; Cavada C; Obeso JA
    Neurobiol Dis; 2010 Jun; 38(3):456-63. PubMed ID: 20304066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-[18F]fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography.
    Nagasawa H; Saito H; Kogure K; Hatazawa J; Itoh M; Fujiwara T; Watanuki S; Seo S; Iwata R; Ido T
    J Neurol Sci; 1993 Apr; 115(2):136-43. PubMed ID: 8482975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and severity of nigrostriatal damage at onset of Parkinson's disease.
    De La Fuente-Fernández R; Lim AS; Sossi V; Adam MJ; Ruth TJ; Calne DB; Stoessl AJ; Lee CS
    Synapse; 2003 Feb; 47(2):152-8. PubMed ID: 12454953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-[18F]fluoro-L-dopa uptake and [76Br]bromolisuride binding in the excitotoxically lesioned caudate-putamen of nonhuman primates studied using positron emission tomography.
    Hantraye P; Loc'H C; Maziere B; Khalili-Varasteh M; Crouzel C; Fournier D; Yorke JC; Stulzaft O; Riche D; Isacson O
    Exp Neurol; 1992 Feb; 115(2):218-27. PubMed ID: 1531196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
    Burn DJ; Sawle GV; Brooks DJ
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study.
    Liu SY; Wu JJ; Zhao J; Huang SF; Wang YX; Ge JJ; Wu P; Zuo CT; Ding ZT; Wang J
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1448-53. PubMed ID: 26559130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.
    Sawle GV; Playford ED; Burn DJ; Cunningham VJ; Brooks DJ
    Arch Neurol; 1994 Mar; 51(3):237-43. PubMed ID: 8129633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.